Literature DB >> 7039375

Surgical pathology of the spleen: an approach to the differential diagnosis of splenic lymphomas and leukemias. Part II. Diseases of the red pulp.

J S Burke.   

Abstract

The diseases which chiefly pertain to the differential diagnosis of splenic lymphomas and leukemias primarily involving the red pulp have been separated into five histologic categories. These include the various forms of congestion, infections, benign and malignant histiocytic proliferations, leukemias and myeloproliferative disorders, and the rare nonhematopoietic tumors of the spleen. Many diseases with major involvement of the red pulp present as hypersplenism of unknown etiology. Accurate diagnosis is particularly dependent on an awareness of the specific histologic manifestations of malignant histiocytosis and the different leukemias in contrast to benign disorders, such as infectious mononucleosis which may simulate malignancy in the splenic red pulp. For each histologic category, therefore, the relevant morphologic features are reviewed, pathophysiologic mechanisms and clinical manifestations correlated, and criteria for differential diagnosis emphasized.

Entities:  

Mesh:

Year:  1981        PMID: 7039375

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.

Authors:  Makoto Kashimura; Masahiro Noro; Bunshiro Akikusa; Atsushi Okuhara; Shuji Momose; Ikuo Miura; Masaru Kojima; Jun-Ichi Tamaru
Journal:  Virchows Arch       Date:  2008-09-26       Impact factor: 4.064

2.  Tumors of the spleen.

Authors:  L Morgenstern; J Rosenberg; S A Geller
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

3.  Splenic pathology in immune thrombocytopenia.

Authors:  M M Hayes; P Jacobs; L Wood; D M Dent
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

4.  Primary splenic lymphoma: Current diagnostic trends.

Authors:  Sachin B Ingle; Chitra R Hinge Ingle
Journal:  World J Clin Cases       Date:  2016-12-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.